1. The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma
   Fayez Estephan et al, 2023, Annals of Diagnostic Pathology CrossRef
2. Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
   Maria Goulielmaki et al, 2023, International Journal of Molecular Sciences CrossRef
3. Targeting the EGFR signaling pathway in cancer therapy: What’s new in 2023?
   Sushanta Halder et al, 2023, Expert Opinion on Therapeutic Targets CrossRef